Kallikrein 4/Prostase/EMSP1 Antibody (KLK4/8942) [mFluor Violet 450 SE]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-27013MFV450
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
Immunohistochemistry-Paraffin
Label
mFluor Violet 450 SE (Excitation = 406 nm, Emission = 445 nm)
Antibody Source
Monoclonal Mouse IgG2b Kappa Clone # KLK4/8942
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary
Immunogen
Recombinant fragment of human Kallikrein 4/Prostase/EMSP1 protein (around aa 1-200) (exact sequence is proprietary)
Localization
Secreted
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2b Kappa
Applications
Application
Recommended Usage
Immunohistochemistry-Paraffin
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Kallikrein 4/Prostase/EMSP1
Alternate Names
ARM1, EMSP1, KLK4, Prostase
Gene Symbol
KLK4
Additional Kallikrein 4/Prostase/EMSP1 Products
Product Specific Notices
mFluor(TM) is a trademark of AAT Bioquest, Inc. This conjugate is made on demand. Actual recovery may vary from the stated volume of this product. The volume will be greater than or equal to the unit size stated on the datasheet.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...